Physician profile
Alex Lee
NPI 1477997476
$1,029.19
in general payments reported to CMS, 2019-2025
15 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.47 · 2020: $120 · 2021: $99.09 · 2022: $51.76 · 2023: $267 · 2024: $95.73 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612 · Entertainment: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.55 |
| Entertainment | $135.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $189.19 | 2025 | Transorb |
| Abbott Laboratories | $158.65 | 2023 | Optis |
| Fisher Scientific Company L.L.C. | $135.72 | 2025 | Procalcitonin |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.15 | 2020 | |
| Spr Therapeutics, INC | $95.73 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $89.25 | 2023 | Rotapro |
| Ethicon US, LLC | $78.22 | 2020-2025 | Proximate, Echelon Circular |
| Ferring Pharmaceuticals INC. | $40.23 | 2021 | |
| Zimmer Biomet Holdings, INC. | $32.36 | 2022 | |
| Olympus America INC. | $25.11 | 2019-2021 | |
| Abbvie INC. | $19.40 | 2022 | |
| Intuitive Surgical, INC. | $19.02 | 2023 | |
| W. L. Gore & Associates, INC. | $18.13 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Innocoll Pharmaceuticals Limited | $14.52 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.